Acupressure Tested for Cough in Lung Cancer Survivors
Tests acupressure against an education booklet for cough in adults with lung cancer.
Plain-language title generated from the registry record
Registry title: Acupressure for Cough in Lung Cancer Survivors
Key facts
- Where
- Hong Kong, Hong KongSee the site
Where in Hong Kong
- Queen Mary HospitalHong Kong, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The University of Hong Kong
- Trial code
- NCT07315672
- Record updated
- 11 August 2026
- Original description
The goal of this randomized controlled trial is to examine the effect of an acupressure intervention in alleviating cough and reducing co-occurring symptoms (dyspnea, cough, and fatigue) in patients with lung cancer.Read full original descriptionShow less
Acupressure for Cough in Lung Cancer Survivors: A Randomized Controlled Trial
The goal of this randomized controlled trial is to examine the effect of an acupressure intervention in alleviating cough and reducing co-occurring symptoms (dyspnea, cough, and fatigue) in patients with lung cancer.
The hypotheses are:
1. Acupressure can alleviate cough in lung cancer survivors; 2. Acupressure can reduce a cough-related symptom cluster (dyspnea-cough-fatigue) experienced by lung cancer survivors; 3. Acupressure can reduce the symptom burden and improve the health-related quality of life and functional capacity of lung cancer survivors experiencing cough.
Participants will:
Receive acupressure for 8 weeks or receive an education booklet; Keep a diary of their acupressure practice and symptoms; Be assessed at baseline (T0), early intervention (T1), post-intervention (T2), and 8 weeks after the intervention period (T3).
Inclusion: be at least 18 years of age; have a diagnosis of LC at any stage and of any pathological type; have a cough symptom rating ≥3 on a 0 to 10 numeric rating scale within 7 days preceding enrollment; can perform acupressure independently in daily activities; be able to read Chinese and communicate in Cantonese or Mandarin; be able to provide informed consent.
Exclusion: have received acupressure or acupuncture within the three months preceding study enrollment; have unstable chronic diseases other than LC; have serious illnesses or other conditions that prevent the participants from following the intervention protocols; have a life expectancy of less than 3 months; Be currently participating in other research programs that may affect the outcomes under investigation.